Zhao Baoping, Li Eileena J, Wall Robert J, Yang Jinzeng
Dept of Human Nutrition, Food and Animal Sciences, University of Hawaii at Manoa, Honolulu, HI 96822, USA.
BMC Genomics. 2009 Jul 8;10:305. doi: 10.1186/1471-2164-10-305.
Skeletal muscle growth and maintenance are essential for human health. One of the muscle regulatory genes, namely myostatin, a member of transforming growth factor-beta, plays a dominant role in the genetic control of muscle mass. Myostatin is synthesized as a precursor protein, which generates the N-terminal propeptide and the C-terminal mature myostatin peptide by a post-translational cleavage event. Previously, transgenic over-expression of myostatin propeptide in skeletal muscle results in significant muscle growth in early stages of development. The objectives of present study were to further characterize muscle growth in later stages of life and to identify genes and their expression patterns that are responsible for adult muscle build-up by myostatin propeptide.
Immunohistochemical staining with an antibody to the N-terminus indicates a high level of myostatin propeptide present in the muscles of transgenic mice while there were no apparent differences in myostatin protein distribution in the muscle fibers between the transgenic and wild-type mice. Main individual muscles increased by 76-152% in the transgenic mice over their wild-type littermate mice at 12 months of age. A large number of nuclei were localized in the central and basal lamina of the myofibers in the transgenic mice as the number of nuclei per fiber and 100 microm(2) area was significantly higher in transgenic mice than wild-type mice. By systemic comparisons of global mRNA expression patterns between transgenic mice and wild-type littermates using microarray and qRT-PCR techniques, we have identified distinct gene expression patterns to support adult muscle build-up by myostatin propeptide, which are comprised of enhanced expressions of myogenic regulatory factors and extracelullar matrix components, and differentially down-regulated expressions of genes related to protein degradation and mitochondrial ATP synthesis.
The results present a coordinated pattern of gene expressions for reduced energy utilization during muscle build-up in adult stage. Enhanced muscle buildup by myostatin propeptide is sustained by reduced ATP synthesis as a result of a decreased activity of protein degradation. Myostatin propeptide may have a therapeutic application to the treatment of clinical muscle wasting problems by depressing myostatin activity.
骨骼肌的生长和维持对人类健康至关重要。肌肉调节基因之一,即肌生成抑制素,是转化生长因子-β家族的成员,在肌肉量的遗传控制中起主导作用。肌生成抑制素以前体蛋白形式合成,通过翻译后切割事件产生N端前肽和C端成熟肌生成抑制素肽。此前,在骨骼肌中过表达肌生成抑制素前肽的转基因小鼠在发育早期会出现显著的肌肉生长。本研究的目的是进一步表征生命后期的肌肉生长情况,并确定负责肌生成抑制素前肽促进成年肌肉生长的基因及其表达模式。
用针对N端的抗体进行免疫组织化学染色表明,转基因小鼠肌肉中存在高水平的肌生成抑制素前肽,而转基因小鼠和野生型小鼠的肌纤维中肌生成抑制素蛋白分布没有明显差异。在12个月大时,转基因小鼠的主要个体肌肉比其野生型同窝小鼠增加了76%-152%。转基因小鼠的大量细胞核位于肌纤维的中央和基膜,因为转基因小鼠每根纤维和100平方微米面积的细胞核数量明显高于野生型小鼠。通过使用微阵列和qRT-PCR技术对转基因小鼠和野生型同窝小鼠之间的全局mRNA表达模式进行系统比较,我们确定了独特的基因表达模式来支持肌生成抑制素前肽促进成年肌肉生长,这些模式包括肌源性调节因子和细胞外基质成分表达增强以及与蛋白质降解和线粒体ATP合成相关的基因表达差异下调。
结果显示了成年期肌肉生长过程中能量利用减少的基因表达协调模式。肌生成抑制素前肽促进的肌肉生长增强是由于蛋白质降解活性降低导致ATP合成减少而得以维持。肌生成抑制素前肽可能通过抑制肌生成抑制素活性,在治疗临床肌肉萎缩问题方面具有治疗应用价值。